Skip to content

Perioperative antibiotic prophylaxis in patients with morbid obesity undergoing laparoscopic sleeve gastrectomy in a certified center of excellence for obesity and metabolic surgery

Perioperative antibiotic prophylaxis in patients with morbid obesity undergoing laparoscopic sleeve gastrectomy in a certified center of excellence for obesity and metabolic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033983
Enrollment
500
Registered
2024-04-08
Start date
2022-09-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

T98.3 E66

Interventions

Group 1: Data from the files (retrospective analysis) of patients with morbid obesity undergoing laparoscopic sleeve gastrectomy without perioperative antibiotic prophylaxis Group 2: Data from the fil

Sponsors

St. Josef KH Bad Driburg KHWE
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: The study included adult patients aged 18 and over with morbid obesity who underwent LSG in the Competence Center for Bariatric Surgery in Bad Driburg between January 1, 2018 and December 31, 2021 for the purpose of weight loss, regardless of gender, BMI and weight or obesity-related comorbidities.

Exclusion criteria

Exclusion criteria: Patients who have already taken antibacterial substances for purposes other than PAP pre- or perioperatively or who stopped taking them more than 7 days preoperatively Patients who have evidence of colonization with germs with known resistance to antibiotics (e.g. MRSA or MRGN) Patients with immune deficiency Patients in whom LSG was undertaken as a bariatric revision procedure (redo operations, e.g. gastric band removal with LSG). Patients who have experienced other complications not related to surgical infection causing an increase in inflammatory parameters or antibiotic therapy and significantly alter the standardized course.

Design outcomes

Primary

MeasureTime frame
Occurrence of a postoperative wound infection

Secondary

MeasureTime frame
Inflammatory parameters in the blood (leukocytes and CRP)

Countries

Germany

Contacts

Public ContactVasilii;Florian Sorokin;Dietl

St. Josef KH;Referenzzentrum für Adipositas- und metabolische Chirurgie Hochstift am St. Josef KH Bad Driburg

soras.vs@gmail.com;t.schmidt@khwe.de+49 152 319 754 10;+4952539852001

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026